Nurses' reported influence on the prescription and use of medication

International Nursing Review

Volumn 57, Issue 1, 2010, Pages 92-97

  Jutel, A ^a   Menkes, D B ^b  

^a OTAGO POLYTECHNIC   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Marketing; Multi Professional education; New Zealand; Nursing; Pharmaceuticals; Staff development

Indexed keywords

ARTICLE; CLINICAL TRIAL; DECISION MAKING; DRUG INDUSTRY; DRUG THERAPY; FEMALE; HUMAN; MALE; MARKETING; MULTICENTER STUDY; NEW ZEALAND; NURSE ATTITUDE; NURSE PATIENT RELATIONSHIP; NURSING; NURSING STAFF; PATIENT EDUCATION; PRESCRIPTION;

DECISION MAKING; DRUG INDUSTRY; DRUG PRESCRIPTIONS; DRUG THERAPY; FEMALE; HUMANS; MALE; MARKETING; NEW ZEALAND; NURSE'S ROLE; NURSE-PATIENT RELATIONS; NURSING STAFF, HOSPITAL; PATIENT EDUCATION AS TOPIC;

EID: 76449106158     PISSN: 00208132     EISSN: 14667657     Source Type: Journal    
DOI: 10.1111/j.1466-7657.2009.00749.x     Document Type: Article

References (39)

1. Nurses, PA 'profound Rx opp for pharma': Pharma Marketletter. 1999, http://www.Marketletter.com, Anon, 22 Nov. [electronic]. Available at: (accessed 25 February 2009)
2. Bayer Schering debuts MS awareness initiative: Pharma Marketletter. 2008, http://www.Marketletter.com, Anon, 26 May. [electronic]. Available at: (accessed 25 February 2009)
3. Alexander-Banys B. Pharmaceutical company advertising practices: call to arms. Journal of Pediatric Health Care 2002, 16(2):49-50.
4. Beuscart-Zéphir M-C. Impact of CPOE on doctor-nurse cooperation for the medication ordering and administration process. International Journal of Medical Informatics 2005, 74(7-8):629-641.
5. Bowron A. Bridging the information gap in primary care. Community Practitioner 2006, 79(8):242.
6. Burns D. Nurse prescribing. Nurses' influence on GPs' prescribing. Nursing Times 2002, 98(43):41-42.
7. Carver N, Ashmore R. Anything to declare? Competing interests in mental health nursing journals. Journal of Psychiatric and Mental Health Nursing 2004, 11(5):620-622.
8. Castledine G. Prescribing is not the only issue for nurses and drugs. British Journal of Nursing (BJN) 2006, 15(15):837-837.
9. Chew LD. A physician survey of the effect of drug sample availability on physicians' behavior. Journal of General Internal Medicine 2000, 15(7):478-483.
10. Edmunds M. Confusing ethical guidelines dampen pharmaceutical support. Nurse Practitioner 2004, 29(8):16.
11. Flewell M. Pharmaceutical sales reps: value beyond samples. Advance for Nurse Practitioners 2006, 14(7):118.
12. Gjerberg E, Kjølsrød L. The doctor-nurse relationship: how easy is it to be a female doctor co-operating with a female nurse? Social Science & Medicine 2001, 52(2):189-202.
13. Jones M. Whose Prescription? A Survey to Examine the Influence of the Practice Nurse on GP Prescribing Patterns for the Therapeutic Categories of Asthma, Diabetes and Hypertension 1995, Royal College of Nursing, London
14. Jutel A, Menkes DB. Soft targets: nursing and the pharmaceutical industry. Public Library of Science Medicine 2008, 5(2):e5.
15. Jutel A, Menkes D. " But doctors do it . . .": nurses' views of gifts and information from the pharmaceutical industry. The Annals of Pharmacotherapy 2009, 43(6):1057-1063.
16. Kaplan L, Brown MA. What is 'true' professional autonomy? The Nurse Practitioner 2006, 31(3):37.
17. Lockwood EB, Gerard MF. Nurse prescribing as an aspect of future role expansion: the views of Irish clinical nurse specialists. Journal of Nursing Management 2008, 16(7):813-820.
18. Mansfield PR. Is it insulting to suggest that health professionals are influenced by drug companies? Healthy Skepticism International News 2007, 25(4). http://www.healthyskepticism.org/news/2007/May.php, Available at: (accessed 18 January 2009)
19. Mansfield PR. Educating health professionals about drug and device promotion: advocates' recommendations. PLoS Medicine 2006, 3(11):e451.
20. Mintzes B. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. British Medical Journal 2002, 324(7332):278-279.
21. Moncrieff J, Hopker S, Thomas P. Psychiatry and the pharmaceutical industry: who pays the piper? Psychiatric Bulletin 2005, 29:84-85.
22. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. British Medical Journal 2002, 324(7342):886-891.
23. Oldani MJ. Thick prescriptions: toward an interpretation of pharmaceutical sales practices. Medical Anthropology Quarterly 2004, 18(3):325-357.
24. Otway C. The development needs of nurse prescribers. Nursing Standard 2002, 16(18):33-38.
25. Pearson S-A, Rolfe I, Smith T. Factors influencing prescribing: an intern's perspective. Medical Education 2002, 36(8):781-787.
26. Pharma marketing eyeing up nurses, report finds. 2008, http://pharmatimes.co.uk/Forums/forums/t/673.aspx, PharmaTimes, Available at: (accessed 8 February 2008
27. Rogelberg SG, Stanton JM. Introduction: understanding and dealing with organizational survey nonresponse. Organizational Research Methods 2007, 10(2):195-209.
28. 1995, http://www.Marketletter.com, Ruder Finn Public Relations, Nurses' evolving role. , 19 June. [electronic]. Available at: (accessed 25 February 2009
29. Sagarin BJ, Cialdini RB, Rice WE, Serna SB. Dispelling the illusion of invulnerability: the motivations and mechanisms of resistance to persuasion. Journal of Personality and Social Psychology 2002, 83(3):526-541.
30. San Martin-Rodriguez L, Beaulieu M, D'Amour D, Ferrada-Videla M. The determinants of successful collaboration: a review of theoretical and empirical studies. Journal of Interprofessional Care 2005, 19(1):132-147. suppl
31. Policy and guidelines for interactions between the Stanford University School of Medicine, the Stanford Hospital and Clinics and Lucile Packard Children's Hospital with the pharmaceutical, biotech, medical device, and hospital and research and supplies industries ('Industry'). 2006, http://med.stanford.edu/coi/siip/documents/siip_policy_aug06.pdf, Stanford University, Available at: (accessed 12 February 2009
32. Stein L. The doctor-nurse game. Archives of General Psychiatry 1968, 16(6):699-703.
33. Sweet S, Norman I. The nurse-doctor relationship: a selection literature review. Journal of Advanced Nursing 1995, 22(1):165-170.
34. Thomas G. 2006, http://www.Marketletter.com, Letter to the editor: new influence on the block (Letter to the editor). , 3 April. [electronic]. Available at: (accessed 25 February 2009
35. Watkins RS, Kimberly J. What residents don't know about physician-pharmaceutical industry interactions. Academic Medicine 2004, 79(5):432-437.
36. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? [Review. Journal of the American Medical Association 2000, 283(3):373-380.
37. Young M. They are more than just pretty people handing out cool pens. Dermatology Nursing 2006, 18(4):323-324.
38. Ziegler M, Lew P, Singer B. The accuracy of drug information from pharmaceutical sales representatives. Journal of the American Medical Association 1995, 273(16):1296-1298.
39. Zipkin DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training. A thematic review. Journal of General Internal Medicine 2005, 20(8):777-786.